Financials

News Discussions Technicals Seasonals

NEVI fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Nevis Brands, Inc. is a biotechnology company, which engages in developing breakthrough treatments in the field of immuno-oncology. It focuses on the following technologies: PAS-403 for glioblastoma, PAS-393 for cancer, and Pre-BCR Antibody for leukemia. The company was founded by Wilfred Jefferies on January 28, 2011 and is headquartered in Seattle, WA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

NEVI has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company